褐藻糖胶
化学
生物化学
脂质过氧化
代谢物
肠粘膜
抗氧化剂
碳酸钙-2
代谢途径
氧化应激
调解人
氧化磷酸化
谷胱甘肽
结肠炎
炎症
肠细胞
代谢组学
线粒体
肠道菌群
作用机理
微生物学
作者
Chunqing Ai,Xiaomeng Ren,Shuang Song,Chunqing Ai
标识
DOI:10.1021/acs.jafc.6c08698
摘要
Fucoidan has shown potential for intestinal protection; however, its underlying mechanisms remain unclear. This study investigated the protective effects of fucoidan against DSS-induced colitis and explored microbiota-associated metabolic changes that were linked to its protective effects. Fucoidan alleviated colonic injury, improved epithelial barrier integrity, and reshaped the gut microbial profile, including reduced Pseudomonadota levels and the enrichment of beneficial taxa. Targeted metabolomics identified citraconic acid (CA) as a candidate metabolite associated with fucoidan-mediated protection. Antibiotic depletion suggested that fucoidan-associated CA accumulation was partially dependent on the gut microbiota. CA reduced colitis severity, attenuated ferroptosis-related oxidative stress, and improved barrier function, accompanied by enhanced Nrf2-associated antioxidant responses and the restoration of SLC7A11 and GPX4 expression. In vitro, CA reduced mitochondrial Fe2+ accumulation and lipid peroxidation while enhancing tight junction protein expression. These results highlight a microbiota-associated metabolic mechanism underlying fucoidan-mediated intestinal protection and identify CA as a potential mediator of its anti-inflammatory activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI